The provincial government of British Columbia will allow midwives to prescribe the abortion pill Mifegymiso and other medications [1, 2].

This policy change aims to improve patient access to reproductive health services by utilizing a broader range of healthcare providers. By expanding the scope of practice for midwives, the province seeks to reduce barriers for individuals seeking abortion medication, particularly in underserved areas [1, 2].

The decision was announced in Victoria, marking a shift in how reproductive care is delivered within the province [1, 2]. Midwives, who have traditionally focused on childbirth and prenatal care, will now have the legal authority to prescribe Mifegymiso, the brand name for mifepristone, as well as other necessary drugs [1, 2].

This expansion is part of a larger effort to integrate reproductive health services into the existing community-based care model. By allowing midwives to handle these prescriptions, the government intends to streamline the process for patients who already have established relationships with their midwifery providers [1, 2].

Officials said the move is designed to ensure that healthcare is more accessible and efficient. The inclusion of these medications in the midwifery scope of practice reflects a broader trend toward diversifying the types of practitioners who can provide essential reproductive services [1, 2].

“British Columbia will allow midwives to prescribe the abortion pill Mifegymiso and other medications.”

This policy shift represents a decentralization of reproductive healthcare in British Columbia. By moving prescription authority from specialized clinics or physicians to midwives, the province is leveraging community-based providers to close gaps in healthcare access, particularly for those in rural or remote regions where specialists are scarce.